Gordon T. Wyatt
Chief Financial Officer

Gordon is CFO for AMV as well as The Innovation Factory. Through his role at The Innovation Factory, he served as CFO of Cerebral Vascular Applications, LipoSonix, AcuFocus, Neuronetics, NeoVista, and OsteoLign and currently serves as CFO for Cellutions, AqueSys and Halscion. Prior to joining The Innovation Factory, Mr. Wyatt was Senior Vice President-Finance for WebMD Corporation; Senior Vice President and Chief Financial Officer at several Dun & Bradstreet Corporation (D&B) companies; and served in senior financial management positions at General Electric Company, including GE’s Corporate Audit Staff. Mr. Wyatt holds a B.S. in accounting and finance from Lehigh University.